Figure 2
Figure 2. Short-term hematopoietic reconstitution by Erg+/Mld2 bone marrow is not sustained. (A) Reconstitution of peripheral blood of lethally irradiated recipients by 1 × 106 GFP+Erg+/+ or GFP+Erg+/mld2 unfractionated bone marrow cells. GFP+ donor contribution is shown; each point is the mean of 4 recipients with 3 independent donors included. *P < .05, **P < .001, ***P ≤ .0001: intragenotype comparison of reconstitution at 4 and 20 weeks after transplantation. (B) Competitive transplantation of GFP+Erg+/Mld2 or GFP+Erg+/+ unfractionated bone marrow cells mixed with competitor Erg+/+ bone marrow into lethally irradiated recipients. Peripheral blood reconstitution of mature lineages assessed at 4 weeks and 20 weeks after transplantation is shown for 1:1 ratio of GFP+Erg+/+ to Erg+/+ and 1:1 and 10:1 ratios of GFP+Erg+/Mld2 to Erg+/+ bone marrow cells. The mean ± SD of GFP+ donor contribution is shown from 3 independent experiments with 4 recipients per transplant. *P < .01, GFP+Erg+/Mld2 1:1 competitive donor ratio compared 1:1 GFP+Erg+/+:Erg+/+ ratio transplant. **P < .01, GFP+Erg+/Mld2 10:1 competitive donor ratio compared with 1:1 GFP+Erg+/+:Erg+/+ ratio transplant.

Short-term hematopoietic reconstitution by Erg+/Mld2 bone marrow is not sustained. (A) Reconstitution of peripheral blood of lethally irradiated recipients by 1 × 106GFP+Erg+/+ or GFP+Erg+/mld2 unfractionated bone marrow cells. GFP+ donor contribution is shown; each point is the mean of 4 recipients with 3 independent donors included. *P < .05, **P < .001, ***P ≤ .0001: intragenotype comparison of reconstitution at 4 and 20 weeks after transplantation. (B) Competitive transplantation of GFP+Erg+/Mld2 or GFP+Erg+/+ unfractionated bone marrow cells mixed with competitor Erg+/+ bone marrow into lethally irradiated recipients. Peripheral blood reconstitution of mature lineages assessed at 4 weeks and 20 weeks after transplantation is shown for 1:1 ratio of GFP+Erg+/+ to Erg+/+ and 1:1 and 10:1 ratios of GFP+Erg+/Mld2 to Erg+/+ bone marrow cells. The mean ± SD of GFP+ donor contribution is shown from 3 independent experiments with 4 recipients per transplant. *P < .01, GFP+Erg+/Mld2 1:1 competitive donor ratio compared 1:1 GFP+Erg+/+:Erg+/+ ratio transplant. **P < .01, GFP+Erg+/Mld2 10:1 competitive donor ratio compared with 1:1 GFP+Erg+/+:Erg+/+ ratio transplant.

Close Modal

or Create an Account

Close Modal
Close Modal